Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
D001778:Blood Coagulation Disorders / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D003646:Debridement / Q000379:methods; D015942:Factor VIIa / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D007813:Laparotomy / Q000379:methods; D008297:Male; D008875:Middle Aged; D019283:Pancreatitis, Acute Necrotizing / Q000150:complications* / Q000473:pathology / Q000601:surgery; D018570:Risk Assessment; D018805:Sepsis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D012720:Severity of Illness Index; D016896:Treatment Outcome
D015942:Factor VIIa